Chitozan Health
PrivateLast Round
Grant
Feb 16, 2024
Total Funding Raised
$254,157
Company Overview
Chitozan Health is a biotechnology company that develops and manufactures a patented antimicrobial technology based on silver chitosan for use in medical devices, textiles, and wound care.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Chitozan Health Comparables
Compare Chitozan Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AG21 Health Sciences, LLC | 87% | |
| Nolla Antimicrobial Oy | 78% | |
| PurThread Technologies | 77% | |
Chitozan Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 16, 2024 | ||||
| Grant | Jul 12, 2022 |
Chitozan Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Suzano Ventures | Accelerator |
| Cycle Momentum | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 16, 2024
$100K raised in grant round.
Chitozan Health Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |